New York is currently home to 4451 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Recruiting
The purpose of this study is to evaluate the safety and tolerability of extended dosing with eplontersen in participants with ATTR-CM.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2024
Locations: New York University Langone Cardiology Associates, New York, New York
Conditions: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
Hospital Airway Resuscitation Trial
Recruiting
The Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2024
Locations: Montefiore Medical Center, New York, New York
Conditions: Cardiac Arrest, Respiratory Failure
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
Recruiting
The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack... Read More
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
11/08/2024
Locations: University at Buffalo (the only clinical site where treatment is delivered), Buffalo, New York
Conditions: Urologic Chronic Pelvic Pain Syndrome (UCPPS), Interstitial Cystitis, Bladder Pain Syndrome, Chronic Prostatitis, Chronic Pain, Chronic Pelvic Pain Syndrome, Chronic Overlapping Pain Disorders
JAK Inhibition in Food Allergy
Recruiting
This study will assess the role for an oral targeted medication, abrocitinib, as a new treatment option for food allergy patients that would avoid injections. Abrocitinib, which has successfully completed phase three trials for atopic dermatitis, could serve as a single therapy for two conditions in many patients with multiple atopic conditions.
Gender:
ALL
Ages:
Between 18 years and 50 years
Trial Updated:
11/08/2024
Locations: Icahn School of Medicine at Mount Sinai, New York, New York
Conditions: Food Allergy
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Recruiting
This is a randomized, double-blind, placebo-controlled, Phase 2/3 study comparing the efficacy and safety of elenestinib (BLU-263) + best supportive care (BSC) with placebo + BSC in patients with indolent systemic mastocytosis (ISM) whose symptoms are not adequately controlled by BSC. Parts 1 and 2 will enroll patients with ISM. Patients enrolled in Part 1 or Part 2 will roll over onto Part 3 to receive treatment with elenestinib in an open-label fashion following completion of the earlier Part.... Read More
Gender:
ALL
Ages:
16 years and above
Trial Updated:
11/08/2024
Locations: Roswell Park Cancer Institute, Buffalo, New York
Conditions: Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome, Smoldering Systemic Mastocytosis
Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome
Recruiting
This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are Retinoic Acid Receptor Alpha (RARA) positive, and newly diagnosed with higher-risk myelodysplastic syndrome (HR-MDS), and who have not received treatment for this diagnosis. The primary goal of the study is to compare the complete remission rate between the two treatment arms.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2024
Locations: Montefiore Medical Center & Albert Einstein College of Medicine, Bronx, New York
Conditions: Myelodysplastic Syndromes
FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
Recruiting
The primary purpose of this study is to evaluate the efficacy of ION363 on clinical function and survival in carriers of fused in sarcoma mutations with amyotrophic lateral sclerosis (FUS-ALS).
Gender:
ALL
Ages:
10 years and above
Trial Updated:
11/08/2024
Locations: Columbia University Medical Center, New York, New York
Conditions: Amyotrophic Lateral Sclerosis
Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
Recruiting
This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2024
Locations: Northwell Health - North Shore University Hospital, Manhasset, New York
Conditions: Post-Concussion Syndrome, Headache
A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors
Recruiting
The purpose of this study is to assess the safety and tolerability of DS-1055a in participants with relapsed or refractory locally advanced or metastatic solid tumors for which no standard treatment is available.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2024
Locations: Memorial Sloan Kettering Cancer Center, New York, New York
Conditions: Solid Tumor, Advanced Cancer, Metastatic Solid Tumor
The Impact of Dietary Pattern on Erectile Function
Recruiting
The goal of this study is to determine whether erectile function is impacted by dietary patterns in healthy men with normal erectile function.
Gender:
MALE
Ages:
Between 18 years and 35 years
Trial Updated:
11/08/2024
Locations: Montefiore Medical Center, Department of Medicine, Division of Cardiology, Bronx, New York
Conditions: Erectile Dysfunction
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study
Recruiting
Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with heart failure and reduced ejection fraction (HFrEF).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/08/2024
Locations: Montefiore Medical Center, Bronx, New York
Conditions: Heart Failure With Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
Recruiting
This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
11/07/2024
Locations: Centers for Vulvovaginal Disorders, NY, New York, New York
Conditions: Vulvar Lichen Sclerosus